Frank Moffat and Paola Ciapetti from NovAliX at Drug Discovery Chemistry 2024

Meet NovAliX Key Opinion Leaders at Drug Discovery Chemistry 2024, a conference dedicated to medicinal and biophysical chemists working in pharma, biotech, and academia. Organized by Cambridge Healthtech Institute (CHI), it will take place in San Diego, CA, from April 1 to 4, 2024. This 19th edition will focus on discovery and optimization challenges of small molecule drug candidates.

Both in-person and online, the event offers plenary keynote sessions and a plenary panel discussion featuring insights from venture capitalists. Some of the topics will include:

  • Targeting transcription factors
  • Covalent modifications and induced proximity
  • Generative AI and predictive modeling
  • Degraders and molecular glues
  • Fragment-based drug discovery
  • Encoded libraries for drug discovery
  • Small molecule immuno-modulators
  • Protein-protein interactions
  • Oral peptides and macrocyclics
  • RNA-modulating small molecule drugs

If you are also attending, do not hesitate to contact NovAliX team at Drug Discovery Chemistry to set a meeting and catch up:

Dr. Frank Moffatt, Senior Director of Business Development

Dr. Paola Ciapetti, Director Alliance Management